ReviewKidney international supplements2022

Clinical perspective-evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.

Peter RossingPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.